Static Chart NovoCure Limited

Equities

Real-time Estimate Cboe BZX Other stock markets 11:27:28 2025-01-14 am EST			5-day change	1st Jan Change
26.70 ^USD	-2.48%		-7.31%	-9.77%

Dec. 02	HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating	MT
Dec. 02	NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint	MT

Duration

Period